MassMutual Private Wealth & Trust’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Hold
294
﹤0.01% 1320
2026
Q1
$9.26K Hold
294
﹤0.01% 1399
2025
Q4
$7.3K Sell
294
-50
-15% -$1K ﹤0.01% 1524
2025
Q3
$5.58K Buy
344
+111
+48% +$1.57K ﹤0.01% 1631
2025
Q2
$3.06K Sell
233
-123
-35% -$1.77K ﹤0.01% 1816
2025
Q1
$7.83K Buy
+356
New +$9.34K ﹤0.01% 1391
2023
Q4
Sell
-102
Closed -$584 1996
2023
Q3
$584 Hold
102
﹤0.01% 1793
2023
Q2
$791 Hold
102
﹤0.01% 1696
2023
Q1
$680 Hold
102
﹤0.01% 1629
2022
Q4
$1K Sell
102
-29
-22% -$272 ﹤0.01% 1435
2022
Q3
$1K Buy
131
+50
+62% +$505 ﹤0.01% 1413
2022
Q2
$1K Buy
+81
New +$612 ﹤0.01% 1301

Other funds holding EWTX

MassMutual Private Wealth & Trust's EWTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 294 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

MassMutual Private Wealth & Trust first reported a position in EWTX in Q2 2022 and has held it in 12 quarters since. 34 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 294 shares of Edgewise Therapeutics worth $11.9K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1320 holding.
  • MassMutual Private Wealth & Trust first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 12 quarters since.
  • 34 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.